Clinical Trial: Epunamin Combined With DECP for Relapsed/Refractory Multiple Myeloma

U.S., March 28 -- ClinicalTrials.gov registry received information related to the study (NCT07497165) titled 'Epunamin Combined With DECP for Relapsed/Refractory Multiple Myeloma' on March 23.

Brief Summary: Background:

Multiple Myeloma remains an incurable hematologic malignancy, and outcomes for relapsed/refractory multiple myeloma (RRMM) remain unsatisfactory despite advances in therapy. This study aims to evaluate the efficacy and safety of Epunamin combined with a DECP-based regimen in a real-world clinical setting.

Methods:

This multicenter, single-arm, real-world observational study will enroll 48 patients aged 18-75 years with RRMM diagnosed according to revised IMWG criteria who have received at least one prior systemic treatme...